Pathogenic Mechanisms of Fibrosis:Common Ground
Pathogenic Mechanisms of Fibrosis:Common Ground
批准号:
6777954
负责人:
ARNOLD E POSTLETHWAITE
金额:
$2.0万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-04-16 至 2004-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
We propose to hold a scientific meeting entitled "Pathogenic Mechanisms of Fibrosis: Search for Common Ground" on April 22-23, 2004 in Memphis, TN. The meeting will take place at the Fogelman Conference Center at the University of Memphis, Memphis, TN and will be jointly sponsored by the University of Tennessee, Memphis, the NIH and Industry. Participants in the meeting will include internationally recognized leaders and experts in the field of fibrosis. Both MD and PhD investigators will be included to provide cross-fertilization of basic science approaches to the understanding of clinically relevant problems. The primary focus will be on common mechanisms and pathways of fibrosis. The focus of this symposium will not be organ specific as is the case with many previous symposia that addresses fibrosis.
Fibrosis is a feature of several arthritic, musculoskeletal and skin diseases such as systemic lupus, erythematosus, rheumatoid arthritis, systemic sclerosis (scleroderma) and morphea. This symposium addresses important topics related to the NtAMS mission. Exciting developments in research in the area of myofibroblast/fibroblast progenitors, novel modulation of myofibroblasts and genetic influence on fibrosis have occurred in the past few years that no doubt will move the field of fibrosis research and novel antifibrotic therapies forward at an accelerated rate. It is the goal of this symposium to facilitate the pace of fibrosis research by bringing together experts to review these new developments in a single forum. The program will specifically address 1) Progenitor Cell Transdifferentiation to Myofibroblasts, 2) Myofibroblast Phenotypic Characteristics and Mediators, 3) Genetics and Fibrosis and, 4) Potential Targets for Treating Fibrosis. Divergent views on these subjects have developed in different laboratories and in different parts of the world. This meeting will address some of those differences and provide a forum for developing new approaches and collaborations. Young investigator travel awards are being provided to encourage involvement of trainees and other young investigators.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Vitamin D-Gelsolin-S1P Axis in Rheumatoid Arthritis
-
批准号:9412753
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
Mechanism of action of 20-hydroxyvitamin D3 in dermal fibroblasts
-
批准号:8833514
-
项目类别:
-
资助金额:$0.57万
-
财政年份:2014
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
Chronic Sleep Restriction Increases Immunity to Autoantigen: Role of the SNS
-
批准号:7941787
-
项目类别:
-
资助金额:$41.84万
-
财政年份:2009
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
Chronic Sleep Restriction Increases Immunity to Autoantigen: Role of the SNS
-
批准号:7830569
-
项目类别:
-
资助金额:$42.73万
-
财政年份:2009
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
Novel Biosynthethic Pathway for Secosteroids and the Skin
-
批准号:8504632
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2006
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
CL CHANNEL ACTIVITY AND FUNCTION IN SYSTEMIC SCLEROSIS MYOFIBROBLASTS
-
批准号:7375445
-
项目类别:
-
资助金额:$0.52万
-
财政年份:2005
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
OPEN LABEL MULTICENTER TRIAL OF ORAL CII TOLERANCE IN RA
-
批准号:7375424
-
项目类别:
-
资助金额:$5.13万
-
财政年份:2005
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
ONE YEAR STUDY OF BOVINE TYPE I COLLAGEN VS PLACEBO IN SSC
-
批准号:7375427
-
项目类别:
-
资助金额:$0.23万
-
财政年份:2005
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
ONE YEAR STUDY OF BOVINE TYPE I COLLAGEN VS PLACEBO IN SSC
-
批准号:7206682
-
项目类别:
-
资助金额:$0.81万
-
财政年份:2004
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
OPEN LABEL MULTICENTER TRIAL OF ORAL CII TOLERANCE IN RA
-
批准号:7206677
-
项目类别:
-
资助金额:$6.87万
-
财政年份:2004
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
Open Label Multicenter Trial of Oral CII Tolerance in RA
-
批准号:7041764
-
项目类别:
-
资助金额:$1.59万
-
财政年份:2003
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
One Year Study of Bovine Type I Collagen vs. Placebo in SSc
-
批准号:7041771
-
项目类别:
-
资助金额:$0.41万
-
财政年份:2003
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
Oral Administration of Lower Doses of Type I Bovine Collagen to Patients w/ Ssc
-
批准号:7041740
-
项目类别:
-
资助金额:$0.09万
-
财政年份:2003
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
Sleep Fragmentation Effects on Murine CII-Induced AR
-
批准号:6665501
-
项目类别:
-
资助金额:$7.15万
-
财政年份:2002
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
Sleep Fragmentation Effects on Murine CII-Induced AR
-
批准号:6561294
-
项目类别:
-
资助金额:$7.15万
-
财政年份:2002
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
SCOR on the Pathogenesis of Scleroderma
-
批准号:6365313
-
项目类别:
-
资助金额:$86.13万
-
财政年份:2001
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
Rheumatic Disease Research Core Center
-
批准号:6943000
-
项目类别:
-
资助金额:$55.21万
-
财政年份:2001
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
SCOR on the Pathogenesis of Scleroderma
-
批准号:6659853
-
项目类别:
-
资助金额:$87.1万
-
财政年份:2001
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
SCOR on the Pathogenesis of Scleroderma
-
批准号:6797753
-
项目类别:
-
资助金额:$88.94万
-
财政年份:2001
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
SCOR on the Pathogenesis of Scleroderma
-
批准号:6532971
-
项目类别:
-
资助金额:$84.87万
-
财政年份:2001
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位: